Surgery Partners (SGRY) Liabilities and Shareholders Equity (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $8.0 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 1.17% year-over-year to $8.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.1 billion (up 3.89% YoY) and the FY2025 annual result came in at $8.1 billion, up 2.91% from the prior year.
• Liabilities and Shareholders Equity retreated to $8.0 billion in Q1 2026 per SGRY's latest filing, from $8.1 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $8.1 billion in Q4 2025, with the low at $6.3 billion in Q1 2022.
• Average Liabilities and Shareholders Equity over 5 years is $7.2 billion, with a median of $7.0 billion recorded in 2024.
• Year-over-year, Liabilities and Shareholders Equity advanced 16.07% in 2022 and gained 1.17% in 2026.
• Surgery Partners' Liabilities and Shareholders Equity stood at $6.7 billion in 2022, then grew by 2.91% to $6.9 billion in 2023, then gained by 14.74% to $7.9 billion in 2024, then gained by 2.91% to $8.1 billion in 2025, then declined by 0.96% to $8.0 billion in 2026.
• Business Quant data shows SGRY's Liabilities and Shareholders Equity at $8.0 billion in Q1 2026, $8.1 billion in Q4 2025, and $7.9 billion in Q3 2025.